The announcement comes as GLP-1 weight loss medications gain popularity and more Americans turn to copycat versions due to ...

Pharmaceutical companies behind weight loss and diabetes medication such as Ozempic are facing a lawsuit that could potentially pay out more than $2 billion. There is multidistrict litigation, or an ...

Novo Nordisk announced up to 50% price cuts for Ozempic and Wegovy diabetes and weight-loss drugs starting January 2027, ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Ozempic’s website says its GLP-1 has more FDA-approved uses than other GLP-1s. Justin Long and John Hodgman star in comedic Ozempic ads to educate about diabetes. The campaign encourages informed ...

The number of people using injectable obesity treatments is increasing rapidly, and it is leading to declines in obesity, according to a new survey by the Gallup National Health and Well-Being Index.

Pharmaceutical companies behind weight loss and diabetes medication such as Ozempic are facing a lawsuit that could potentially pay out more than $2 billion. Rating: Mostly True (About this rating?) ...